Glucagon-like peptide-1 receptor agonist use in pregnancy: A review
Increased intracellular Ca2+ concentrations trigger fusion of insulin-containing granules with the plasma membrane and insulin secretion from the cells
Pregnancy and breastfeeding are not recommended
While clinical trials have provided valuable insights, further research is should determine the optimal use of these agents in different heart failure populations
The enzyme dipeptidyl peptidase 4 (DPP-4) cleaves active GLP-1 (7-36) amide and (7-37) non-amide after secretion from the gut and brain, forming two GLP-1 metabolites 8,10,12,13
Looking ahead, Al-Aly said, the findings support the case for clinical trials to test GLP-1 medications as treatments for addiction in their own right, including trials powered to measure effects on overdose and drug-related death